Home » 3-Dimensional Pharma Receives Patent for High-Throughput Technology

3-Dimensional Pharma Receives Patent for High-Throughput Technology

Apr 07, 2000
Premium

E

XTON, Pa.--3-Dimensional Pharmaceuticals has received its second patent on a method for getting quantitative measurements of drug-binding affinity to almost any protein or nucleic acid target--a technology the company calls ThermoFluor. The first patent, announced earlier this year, covered the assay methodology while the new patent covers the assay apparatus.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

What's Popular?

In Informatics

  1. Google Deep Learning May Improve SNP Analysis, But Don't Call It AI Anytime Soon

    Premium

  2. CHOP to Head NIH-Backed Data Center for Pediatric Cancer Research

  3. Cell-Free DNA Shotgun Sequencing Method Detects Transplant Rejection

    Premium

  4. New Tool Identifies Non-Coding Genomic Regions Likely to Harbor Pathogenic Variants

  5. Geneformics Sees Lossless Compression as Answer to Cloud Genomics

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.